Aims and Scope of Clinical Genitourinary Cancer
Clinical Genitourinary Cancer is a peer-reviewed medical journal published by Elsevier, and previously by CIG Media Group (Cancer Information Group). The journal publishes articles on detection, diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments in all areas related to genitourinary cancers. The journal was previously published as Clinical Prostate Cancer through September 2005. Less
Key Metrics
CiteScore 

5.5
Impact Factor 

< 5
SJR 

Q2Urology

SNIP 

0.97
Recommended pre-submission checks
Powered by 

Topics Covered on Clinical Genitourinary Cancer
Clinical Genitourinary Cancer Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | CIG MEDIA GROUP, LP |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2002 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Clinical Genitourinary Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Clinical Genitourinary Cancer
A Real-World Prospective Study of Comprehensive Genomic Testing in Patients With Metastatic Castration-Resistant Prostate Cancer.
- 1 Aug 2026
- Clinical genitourinary cancer
Targeting HER2 in Urothelial Carcinoma: Why Histologic Subtypes and Divergent Histologies Matter.
- 1 Aug 2026
- Clinical genitourinary cancer
Corrigendum to "Urinary Exosomal miR-17-5p Accelerates Bladder Cancer Invasion by Repressing its Target Gene ARID4B and Regulating the Immune Microenvironment" [Clinical Genitourinary Cancer 22/2 (2024) 569-579.e1
- 1 Aug 2026
- Clinical genitourinary cancer
Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature.
- 1 Aug 2026
- Clinical genitourinary cancer
Toward Interpretable Machine Learning Models for Grading Prostate Cancer: A Multicenter Development and Validation Study.
- 1 Aug 2026
- Clinical genitourinary cancer
Robust Meta-Analysis of a Clinical Cell-Cycle Risk (CCR) Score Demonstrates Broadly Applicable Metastasis and Disease-Specific Mortality Risk Stratification in Men With Localized Prostate Cancer.
- 1 Aug 2026
- Clinical genitourinary cancer
A Real-World Prospective Study of Comprehensive Genomic Testing in Patients With Metastatic Castration-Resistant Prostate Cancer.
- 1 Aug 2026
- Clinical genitourinary cancer
Targeting HER2 in Urothelial Carcinoma: Why Histologic Subtypes and Divergent Histologies Matter.
- 1 Aug 2026
- Clinical genitourinary cancer
Corrigendum to "Urinary Exosomal miR-17-5p Accelerates Bladder Cancer Invasion by Repressing its Target Gene ARID4B and Regulating the Immune Microenvironment" [Clinical Genitourinary Cancer 22/2 (2024) 569-579.e1
- 1 Aug 2026
- Clinical genitourinary cancer
Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature.
- 1 Aug 2026
- Clinical genitourinary cancer
Toward Interpretable Machine Learning Models for Grading Prostate Cancer: A Multicenter Development and Validation Study.
- 1 Aug 2026
- Clinical genitourinary cancer
Robust Meta-Analysis of a Clinical Cell-Cycle Risk (CCR) Score Demonstrates Broadly Applicable Metastasis and Disease-Specific Mortality Risk Stratification in Men With Localized Prostate Cancer.
- 1 Aug 2026
- Clinical genitourinary cancer